• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Cytomegalovirus viremia, pneumonitis, and tocilizumab therapy.

作者信息

van Duin David, Miranda Cyndee, Husni Elaine

出版信息

Emerg Infect Dis. 2011 Apr;17(4):754-6. doi: 10.3201/eid1706.101057.

DOI:10.3201/eid1706.101057
PMID:21470484
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3377404/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7e9/3377404/319e6a050db2/10-1057-F.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7e9/3377404/319e6a050db2/10-1057-F.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7e9/3377404/319e6a050db2/10-1057-F.jpg

相似文献

1
Cytomegalovirus viremia, pneumonitis, and tocilizumab therapy.巨细胞病毒血症、肺炎与托珠单抗治疗
Emerg Infect Dis. 2011 Apr;17(4):754-6. doi: 10.3201/eid1706.101057.
2
Cytomegalovirus reactivation during alemtuzumab therapy for chronic lymphocytic leukemia: incidence and treatment with oral ganciclovir.阿仑单抗治疗慢性淋巴细胞白血病期间的巨细胞病毒再激活：发病率及口服更昔洛韦治疗
Haematologica. 2004 Oct;89(10):1248-52.
3
Acute cytomegalovirus pneumonitis in patient with lymphomatoid granulomatosis.淋巴瘤样肉芽肿病患者的急性巨细胞病毒性肺炎
Emerg Infect Dis. 2011 Apr;17(4):741-2. doi: 10.3201/eid1704.101035.
4
Alemtuzumab induced complete remission of autoimmune hemolytic anemia refractory to corticosteroids, splenectomy and rituximab.阿仑单抗使对皮质类固醇、脾切除术及利妥昔单抗均难治的自身免疫性溶血性贫血完全缓解。
Haematologica. 2006 May;91(5 Suppl):ECR13.
5
Early postoperative recurrence of severe Crohn's disease, with colonic involvement and associated human cytomegalovirus infection, treated with oral valganciclovir and adalimumab.早期术后复发的重度克罗恩病，累及结肠并伴有人巨细胞病毒感染，采用口服缬更昔洛韦和阿达木单抗治疗。
Inflamm Bowel Dis. 2011 Jun;17(6):E43-4. doi: 10.1002/ibd.21685. Epub 2011 Mar 21.
6
Cytomegalovirus colitis complicating ulcerative colitis treated with adalimumab.巨细胞病毒性结肠炎并发溃疡性结肠炎，接受阿达木单抗治疗。
Scand J Gastroenterol. 2010 Apr;45(4):509-10. doi: 10.3109/00365520903583871.
7
Cytomegalovirus DNAemia and disease: incidence, natural history and management in settings other than allogeneic stem cell transplantation.巨细胞病毒血症与疾病：异基因造血干细胞移植以外情况下的发病率、自然史及管理
Haematologica. 2005 Dec;90(12):1672-9.
8
Usefulness of pp65 antigenemia and viremia in the follow-up of renal transplant recipients with cytomegalovirus disease treated with ganciclovir.pp65抗原血症和病毒血症在接受更昔洛韦治疗的肾移植巨细胞病毒病患者随访中的作用
Diagn Microbiol Infect Dis. 2000 Jun;37(2):83-6. doi: 10.1016/s0732-8893(00)00126-7.
9
[Impact of initial cytomegalovirus viral load on efficacy of preemptive therapy with ganciclovir in allogeneic stem cell transplant recipients].[初始巨细胞病毒病毒载量对异基因干细胞移植受者更昔洛韦抢先治疗疗效的影响]
Enferm Infecc Microbiol Clin. 2010 Jan;28(1):6-12. doi: 10.1016/j.eimc.2009.01.010. Epub 2009 May 1.
10
Fatal disseminated cytomegalovirus infection associated with infliximab and 6-mercaptopurine therapy in a child with Crohn disease.一名克罗恩病患儿在接受英夫利昔单抗和6-巯基嘌呤治疗后发生致命性播散性巨细胞病毒感染。
Pediatr Infect Dis J. 2009 Jun;28(6):556. doi: 10.1097/INF.0b013e3181a39571.

引用本文的文献

1
Cytomegalovirus Retinitis in a Patient Taking Tocilizumab: A Case Report.一名服用托珠单抗患者的巨细胞病毒性视网膜炎：病例报告
J Vitreoretin Dis. 2020 Mar 12;4(3):233-235. doi: 10.1177/2474126420910587. eCollection 2020 Jun.
2
Outcomes of Cytomegalovirus Viremia Treatment in Critically Ill Patients With COVID-19 Infection.新型冠状病毒肺炎（COVID-19）感染重症患者巨细胞病毒血症治疗的结果
Open Forum Infect Dis. 2022 Jun 10;9(7):ofac286. doi: 10.1093/ofid/ofac286. eCollection 2022 Jul.
3
Cytomegalovirus pneumonitis amid COVID-19 chaos: the hidden enemy-a case report.

本文引用的文献

1
Safety and efficacy profiles of tocilizumab monotherapy in Japanese patients with rheumatoid arthritis: meta-analysis of six initial trials and five long-term extensions.托珠单抗单药治疗日本类风湿关节炎患者的安全性和疗效：六项初始试验和五项长期扩展的荟萃分析。
Mod Rheumatol. 2010 Jun;20(3):222-32. doi: 10.1007/s10165-010-0279-5. Epub 2010 Mar 11.
2
Tumor necrosis factor blockade and the risk of viral infection.肿瘤坏死因子阻断与病毒感染风险。
Nat Rev Rheumatol. 2010 Mar;6(3):165-74. doi: 10.1038/nrrheum.2009.279. Epub 2010 Feb 9.
3
Long-term safety and efficacy of tocilizumab, an anti-IL-6 receptor monoclonal antibody, in monotherapy, in patients with rheumatoid arthritis (the STREAM study): evidence of safety and efficacy in a 5-year extension study.
COVID-19 大流行期间的巨细胞病毒肺炎：隐匿的敌人——1 例病例报告。
J Med Case Rep. 2022 Jan 31;16(1):58. doi: 10.1186/s13256-022-03259-0.
4
COVID-19-associated opportunistic infections: a snapshot on the current reports.COVID-19 相关机会性感染：当前报告简述。
Clin Exp Med. 2022 Aug;22(3):327-346. doi: 10.1007/s10238-021-00751-7. Epub 2021 Aug 23.
5
Tocilizumab-induced cytomegalovirus colitis in a patient with COVID-19.托珠单抗诱发的新冠病毒病患者巨细胞病毒性结肠炎
Clin Case Rep. 2020 Nov 12;9(1):148-152. doi: 10.1002/ccr3.3487. eCollection 2021 Jan.
6
Impact of interleukin-6 blockade with tocilizumab on SARS-CoV-2 viral kinetics and antibody responses in patients with COVID-19: A prospective cohort study.托珠单抗阻断白细胞介素 6 对 COVID-19 患者 SARS-CoV-2 病毒动力学和抗体反应的影响：一项前瞻性队列研究。
EBioMedicine. 2020 Oct;60:102999. doi: 10.1016/j.ebiom.2020.102999. Epub 2020 Sep 16.
7
A Case of Coinfection with SARS-COV-2 and Cytomegalovirus in the Era of COVID-19.COVID-19时代的1例严重急性呼吸综合征冠状病毒2型与巨细胞病毒合并感染病例
Eur J Case Rep Intern Med. 2020 Apr 11;7(5):001652. doi: 10.12890/2020_001652. eCollection 2020.
抗白细胞介素-6受体单克隆抗体托珠单抗单药治疗类风湿关节炎患者的长期安全性和疗效（STREAM研究）：一项5年延长期研究的安全性和疗效证据
Ann Rheum Dis. 2009 Oct;68(10):1580-4. doi: 10.1136/ard.2008.092866. Epub 2008 Nov 19.
4
Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: the tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study.使用托珠单抗抑制白细胞介素-6受体可降低对改善病情抗风湿药物反应不足的类风湿关节炎患者的疾病活动度：托珠单抗联合传统改善病情抗风湿药物治疗研究
Arthritis Rheum. 2008 Oct;58(10):2968-80. doi: 10.1002/art.23940.
5
Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial.托珠单抗治疗全身型幼年特发性关节炎患者的疗效和安全性：一项随机、双盲、安慰剂对照、撤药期III期试验
Lancet. 2008 Mar 22;371(9617):998-1006. doi: 10.1016/S0140-6736(08)60454-7.
6
Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial.托珠单抗抑制白细胞介素-6受体对类风湿关节炎患者的影响（OPTION研究）：一项双盲、安慰剂对照的随机试验。
Lancet. 2008 Mar 22;371(9617):987-97. doi: 10.1016/S0140-6736(08)60453-5.
7
Serious infection following anti-tumor necrosis factor alpha therapy in patients with rheumatoid arthritis: lessons from interpreting data from observational studies.类风湿关节炎患者接受抗肿瘤坏死因子α治疗后的严重感染：从观察性研究数据解读中获得的经验教训
Arthritis Rheum. 2007 Sep;56(9):2896-904. doi: 10.1002/art.22808.
8
Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial.人源化抗白细胞介素-6受体抗体治疗类风湿关节炎：一项多中心、双盲、安慰剂对照试验。
Arthritis Rheum. 2004 Jun;50(6):1761-9. doi: 10.1002/art.20303.
9
Cytokines and immunity to viral infections.细胞因子与病毒感染免疫
Immunol Rev. 1997 Oct;159:119-35. doi: 10.1111/j.1600-065x.1997.tb01011.x.